Search - tctmd.com

Displaying 641 - 660 of 2546

Sort: Relevancy | Date

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2020

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Presenter: Daniel Burkhoff

October 17, 2020

Presentation TCT 2020

Acute Decompensated Heart Failure: Drugs and Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

October 17, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

Presentation TCT 2020

FMR: Targeting the Annulus: Devices, Advantages, and Potential Limitations

Presenter: Georg Nickenig

October 16, 2020

Presentation TCT 2020

DMR: Targeting the Chords – Devices, Advantages, and Potential Limitations

Presenter: Michael Borger

October 16, 2020

Presentation TCT 2020

Regulatory Viewpoints on MCS Device Approval

Presenter: Meir Shinnar

October 16, 2020

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

L.A. McKeown

October 16, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

Presentation TCT 2020

PVL Prevention and Management: TAVR Device Selection, When to Post-Dilate, and When to Plug

Presenter: Hemal Gada

October 16, 2020

Presentation TCT 2020

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Presenter: Manuela Negoita

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

Device-Based Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

October 15, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

Advertisement

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Acute Decompensated Heart Failure: Drugs and Devices (DRIIPPS)

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

FMR: Targeting the Annulus: Devices, Advantages, and Potential Limitations

DMR: Targeting the Chords – Devices, Advantages, and Potential Limitations

Regulatory Viewpoints on MCS Device Approval

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

PVL Prevention and Management: TAVR Device Selection, When to Post-Dilate, and When to Plug

Industry Sponsors (Supporting Innovation and Medical Device Approval)

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Device-Based Approaches to Infarct Size Reduction

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content